Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 4Sleep Apnea, Obstructive 2Sleep Apnea Syndromes 1Obesity 1Metabolic Syndrome 1Insulin Resistance 1Hyperandrogenism 1Glucose Intolerance 1

Interventions

Metformin 7Exenatide 4Vitamin D 2Sugars 2Resistance Training 2penclomedine 1licogliflozin 1exemestane 1dapagliflozin 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Weight Reduction Programs 1Therapeutics 1Testosterone 1Taxes 1Tamoxifen 1TOPS 1Surveys and Questionnaires 1Sugammadex 1Sodium-Glucose Transporter 2 Inhibitors 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Qsymia 1Progesterone 1Paclitaxel 1Observation 1Nutrition Assessment 1Naltrexone 1Methods 1Letrozole 1Jogging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Obesity × Estrogens × Clear all
NCT00805207 2018-08-01

SCOR

Washington University School of Medicine

Phase NA Completed
61 enrolled 17 charts
Other

Obesity, Polycystic Ovary Syndrome, Sleep Apnea Syndromes, Sleep Apnea, Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡